| Editor's Choice: Cardiac Imaging | Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists. Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists. | | |
| “We believe this case is potentially groundbreaking," one interventional cardiologist said. “We believe this case is potentially groundbreaking," one interventional cardiologist said. | | |
| CT-FFR, which recently got a boost from the 2021 AHA/ACC chest pain guidelines, could play a key role for clinicians hoping to screen TAVR patients for coronary heart disease. CT-FFR, which recently got a boost from the 2021 AHA/ACC chest pain guidelines, could play a key role for clinicians hoping to screen TAVR patients for coronary heart disease. | | |
| More than 3,500 college athletes with a confirmed COVID-19 diagnosis were included in the new study. The median follow-up period was more than one full year. More than 3,500 college athletes with a confirmed COVID-19 diagnosis were included in the new study. The median follow-up period was more than one full year. | | |
| Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques. Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques. | | |
| HeartFlow’s non-invasive cardiac computed tomography derived fractional flow reserve (FFR-CT) technology enables FFR values for the entire coronary tree of a patient using just a CT scan. This can show the significance of any coronary plaque lesions and if a patient needs to be sent to the cath lab for revascularization, or if they can be treated medically. HeartFlow’s non-invasive cardiac computed tomography derived fractional flow reserve (FFR-CT) technology enables FFR values for the entire coronary tree of a patient using just a CT scan. This can show the significance of any coronary plaque lesions and if a patient needs to be sent to the cath lab for revascularization, or if they can be treated medically. | | |
| |
|
| ![]() | |
|
